Bolus injection of aqueous antigen leads to a high density of T-cell- receptor ligand in the spleen, transient T-cell activation and anergy induction

Immunology

Volumn 94, Issue 4, 1998, Pages 513-522

  Switzer, S K ^a   Wallner, B P ^a   Briner, T J ^a   Sunshine, G H ^a   Bourque, C R ^a   Luqman, M ^a,b  

^a ImmuLogic Pharmaceutical Corporation   (United States)

^b Peptimmune Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CLONAL ANERGY; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ANTIGENS; CLONAL ANERGY; CYTOCHROME C GROUP; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; SPLEEN; T-LYMPHOCYTES;

EID: 0031831855     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00554.x     Document Type: Article

References (45)

1. GOODNOW C.C. (1996) Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad sci USA 93, 2264.
2. MONDINO A., KHORUTS A. & JENKINS M.K. (1996) The anatomy of T-cell activation and tolerance. Proc Natl Acad Sci USA 93, 2245.
3. KRUISBEEK A.M. & AMSEN D. (1996) Mechanisms underlying T-cell tolerance. Curr Opin Immunol 8, 233.
4. MITCHISON N.A. (1964) Induction of immunological paralysis in two zones of dosage. Proc R Soc London Ser 161, 275.
5. DRESSER D.W. & MITCHISON N.A. (1968) The mechanism of immunological paralysis. Adv Immunol 8, 129.
6. SISKIND G.W. & BENACERRAF B. (1969) Cell selection by antigen in the immune response. Adv Immunol 10, 1.
7. WEIGLE W.O. (1973) Immunological unresponsiveness. Adv Immunol 16, 61.
8. WEIGLE W.O. (1980) Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis. Adv Immunol 30, 159.
9. DRESSER D.W. (1961) Effectiveness of lipid and lipophilic substances as adjuvants. Nature 191, 1169.
10. CHILLER J.M., HABICHT G.S. & WEIGLE W.O. (1971) Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science 171, 813.
11. RIA F., CHEN B.M.C., SCHERER M.T., SMITH J.A. & GEFTER M.L. (1990) Immunological activity of covalently linked T cell epitopes. Nature 343, 381.
12. DE WIT D., VAN MECHELEN M., RYELANDT M. et al. (1992) The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes. J Exp Med 175, 9.
13. BURSTEIN H.J., SHEA C.M. & ABBAS A.K. (1992) Aqueous antigens induce in vivo tolerance selectively in IL-2- and IFN-γ-producing (Th1) cells. J Immunol 148, 3687.
14. DE SMEDT PAJAK B., MURAILL E., LESPAGNARD L. et al. (1996) Regulation of dendritic cell number and maturation by lipopolysaccharide in vivo. J Exp Med 184, 1413.
15. LIU Y. & JANEWAY C.A. (1991) Microbial induction of costimulatory activity for CD4+ T-cell growth. Intl Immunol 3, 323.
16. GUPTA R.K. & SIBER G.R. (1995) Adjuvant for human vaccines current status, problems and future prospects. Vaccine 13, 1263.
17. WARREN H.S., VOGEL F.R. & CHEDID L.A. (1996) Current status of immunological adjuvants. Annu Rev Immunol 4, 369.
18. BERG L.J., PULLEN A.M., FAZEKAS DE ST. GROTH B., MATHIS D., BENOIST C. & DAVIS M.M. (1989) Antigen/MHC-specific T cells arc preferentially exported from the thymus in the presence of their MHC ligand. Cell 58, 1035.
19. FALB D., BRINER T.J., SUNSHINE G.H. et al. (1996) Peripheral tolerance in T cell receptor-transgenic mice: evidence for T cell anergy. Eur J Immunol 26, 130.
20. SAMELSON L.E., GERMAIN R.N. & SCHWARTZ R.H. (1983) Monoclonal antibodies against the antigen receptor on a cloned T-cell hybrid. Proc Natl Acad Sci USA 80, 6972.
21. SAMSON M.F. & SMILEK D.E. (1995) Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC Complexes. J Immunol 155, 2737.
22. MÜLLER K., SCHUMACKER J. & KYEWSKI B.A. (1993) Half-life of antigen/major histocompatibility complex class II complexes in vivo: intra- and interorgan variations. Eur J Imnnmol 23, 3203.
23. ELLIOTT E.A., MCFARLAND H.I., NYE S.H. et al. (1996) Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J Clin Invest 98, 1602.
24. COUSULICH M.E., RUBARTELLI A., Risso A., COZZOLINO F. & BARGELLESI A. (1987) Functional characterization of an antigen involved in an early step of T-cell activation. Proc Natl Acad Sci USA 84, 4205.
25. BRINER T.M., KUO M.-C., KEATING K.M., ROGERS B.L. & GREENSTEIN J.L. (1993) Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d 1. Proc Natl Acad Sci USA 90, 7608.
26. VIDARD L., COLARUSSO L.J. & BENACERRAF B. (1994) Specific T-cell tolerance may be preceded by a primary response. Proc Natl Acad Sci USA 91, 5627.
27. KEARNEY E.R., PAPE K.A., LOH D.Y. & JENKINS M.K. (1994) Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1, 327.
28. ZHONG G., SOUSA C.R. & GERMAIN R.N. (1997) Antigen unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complex after soluble protein exposure in vivo or in vitro. J Exp Med 186, 673.
29. LIU G.Y. & WRAITH D.C. (1995) Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice- implications for autoimmunity. Int Immunol 7, 1225.
30. QUILL H. (1996) Anergy as a mechanism of peripheral T cell tolerance. J Immunol 156, 1328.
31. SCHWARTZ R. (1996) Models of T cell anergy: Is there a common molecular mechanism? J Exp Med 184, 1.
32. + T-cell stimulation. Prog Immunol 7, 572.
33. MUELLER D.L. & JENKINS M.K. (1995) Molecular mechanism underlying functional T-cell unresponsiveness. Curr Opin Immunol 7, 375.
34. + T cells precedes the development of tolerance in vivo. Int Immunol 8, 335.
35. LIBLAU R.S., TISTH R., SHOKAT K. et al. (1996) Intravenous injection of soluble antigen induces thymic and peripheral T-cell apoptosis. Prot Natl Acad Sci USA 93, 3031.
36. PAPE K.A., KEARNEY E.R., KHORUTS A. et al. (1997) Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cells for the study of T-cell activation in vivo, Immunol Rev 156, 67.
37. ROGERS W.O., WEAVER C.T., KRAUS L.A., LI J., LI L. & BUCY R.P. (1997) Visualization of antigen-specific T cell activation and cytokine expression in vivo. J Immunol 158, 649.
38. LIU G.Y., FAIRCHILD P.J., SMITH R.M., PROWLE J.R., KIOUSSIS R.M. & WRAITH D.C. (1995) Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3, 407.
39. + T cells from tolerance induction by the superantigen staphylococcal enterotoxin B. Eur J Immunol 26, 858.
40. PEREZ V.L., PARUS L.V., BIUCKIANS A., ZHENG X.X., STROM T.B. & ABBAS A.K. (1997) Induction of peripheral T cell tolerance in vivo requires CTLA-4 Engagement. Immunity 6, 411.
41. WEBB S., MORRIS C. & SPRENT J. (1995) Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63, 1249.
42. RENNO T., HAHNE M. & MACDONALD H.R. (1995) Proliferation is a prerequisite for bacterial superantigen-induced T cell apoptosis in vivo. J Exp Med 181, 2283.
43. + T cells. J Exp Med 182, 1591.
44. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J Exp Med 182, 1579.
45. BRETSCHER P.A., WEI G., MENON J.N. & BIELEFELDT-OHMANN H. (1992) Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 257, 539.